Submitted by Anonymous (not verified) on 12 July 2024 - 15:06
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 15, Status: Authorised